期刊文献+

P16^(INK4A)在宫颈癌及癌前病变脱落细胞中表达的临床意义及其与HPV16、18型的关系 被引量:2

Study on the expression of P16~INK4A in the cytological specimen of cervical carcinoma and precancerous diseases and it's relationship to HPV types 16 and 18.
下载PDF
导出
摘要 目的:观察p16IND4A能否作为宫颈癌、宫颈癌前病变标志物及其与HPV16、18型的关系。方法: 采用免疫组织化学S-P方法,检测p16IND4A在宫颈脱落细胞中表达。同时,采用FQ-PCR技术检测HPV16、18 型DNA。结果:9例宫颈鳞状细胞癌P16INK4A表达均为阳性;45例LSIL,44例P16INK4A表达为阳性,仅1例为阴性;38例的HSIL均为阳性;30例中ASC有10例阳性,20例正常宫颈及40例慢性宫颈炎,P16INK4A染色均为阴性。HPV16、18型DNA阳性率分别为8/9、31.1%、68.4%、33.3%。40例慢性宫颈炎HPV16、18 型DNA阳性1例,正常宫颈细胞未检测出HPV16、18型DNA。结论:HPV16、18型DNA阳性率及阳性标本拷贝数愈高,P16INK4A表达的强度愈强。p16INK4A有望成为宫颈癌前病变诊断标志物。 Objective: To investigate whether P16^INK4A can be an indicator in the diagnosis of cervical carcinoma and precancerous diseases. Method: Immunohistochemistry (SP method) was employed to detect the expression of P16^INK4A in the cytology specimen of cervix. And FQ-PCR technology was used to detect the expression of HPV types 16 and 18 DNA. Results: P16^INK4A positive was found in all 9 cases of cervical squamous carcinoma and 38 cases of HSIL. Among 45 case of LSIL, 44 cases were found P16^INK4A positive. While in 30 cases of ASC only 10 were found P16^INK4A positive and none of 20 cases of normal cervix and 40 cases of chronic cervicitis were found positive. The positive rates of HPV types 16 and 18 DNA expression were 88.9%, 31.1%, 68.4% and 33.3% in squamous cervical carcinoma, LSIL, HSIL and ASC, respectively. HPV types 16 and 18 DNA positive was found in only one case of chronic cervicitis and none of normal cervix was found positive. The higher the positive rates and copies of HPV types 16 and 18 DNA expression, the stronger the expression of P16^INK4A was found. Conclusion: P16^INK4A may become a useful indicator in the diagnosis of cervical precancerous diseases.
出处 《温州医学院学报》 CAS 2005年第4期294-297,共4页 Journal of Wenzhou Medical College
关键词 P16^INK4ATBSFQ—PCR宫颈癌前病变 P16^INK4A TBS FQ-PCR cervical precancerous disease
  • 相关文献

参考文献11

  • 1Murphy N, Ring M, Killalea AG,et al. P16^INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears[J]. J Clin Pathol, 2003, 56(1): 56-63.
  • 2邹先进,蔡兰,刘颖,王梅,谢军花.子宫颈癌前病变与子宫颈癌组织中p16^(INK4A)蛋白检测及其与人乳头状瘤病毒感染的关系[J].中华妇产科杂志,2004,39(9):625-626. 被引量:25
  • 3Ishikawa A, Sasaki M, Sato Y, et al. Frequent p 16^INK4A inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis[J]. Hum Pathol, 2004,35(12): 1505-1514.
  • 4Tanaka R, Wang D, Morishita Y, et al. Loss of function of pl6gene and prognosis of pulmonary adenocarcinoma[J]. Cancer.2005, 103(3):608-615.
  • 5Negri G, Egarter-Vigl E, Kasal A, et al. P16^INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations[J]. Am J Surg Pathol, 200327(2): 187-193.
  • 6Saqi A, Pasha TL, McGrath CM, et al. Overexpression of p16^INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia[J]. Diagn Cytopathol,2002, 27(6): 365-370.
  • 7van de Putte G, Holm R, Lie AK, et al. Expression of p27,p21, and p 16 protein in early squamous cervical cancer and its relation to prognosis[J]. Gynecol Oncol, 2003, 89(1 ): 140-147.
  • 8Bibbo M, DeCecco J, Kovatich AJ. P16^INK4A as an adjunct test in liquid-based cytology[J]. Anal Quant Cytol Histol,2003, 25(1): 8-11.
  • 9Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis[J].Adv Anat Pathol, 2001, 8(2): 83-92.
  • 10Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p 16^INK4A are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia[J]. Am J Surg Pathol, 2001, 25(7): 884-891.

二级参考文献6

  • 1Negri G,Egarter-Vigl E,Kasal A,et al.p16 INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.Am J Surg Pathol,2003 ,27:187-193.
  • 2Keating JT,Ince T,Crum CP.Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.Adv Anat Pathol 2001,8:83-92.
  • 3Keating JT,Cviko A,Riethdorf S,et al.Ki-67,cyclin E,and p16 INK4A are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.Am J Surg Pathol,2001 ,25:884-891.
  • 4Murphy N,Ring M,Killalea AG,et al.p16 INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.J Clin Pathol,2003 ,56:56-63.
  • 5Bibbo M,Klump WJ,DeCecco J,et al.Procedure for immunocytochemical detection of p16 INK4A antigen in thin-layer,liquid-based specimens.Acta Cytol,2002 ,46:25-29.
  • 6郎景和.迎接子宫颈癌预防的全球挑战与机遇[J].中华妇产科杂志,2002,37(3):129-131. 被引量:884

共引文献37

同被引文献28

  • 1周志韶,马澄城,黄壮国,周晓军,赵毅.广东潮阳地区海尔曼螺杆菌感染的研究[J].中华消化内镜杂志,2005,22(3):195-197. 被引量:6
  • 2丁益宏,黄剑飞,黄华.食管鳞癌中CDK4表达及意义的研究[J].河南肿瘤学杂志,2004,17(4):241-242. 被引量:4
  • 3陈伟三,蔡树深,邱杰文,朱莉煌,林昆,陈红英,刘艳红,郭良明,许统琪,袁辉,张梓杨,陈榕生.广东省揭阳市食管癌流行病学调查[J].癌症,1994,13(2):159-161. 被引量:8
  • 4吴库生,李克.基于地理信息系统的广东省食管癌地理流行病学研究[J].汕头大学医学院学报,2006,19(4):230-232. 被引量:14
  • 5RIETHDORF S, NEFFEN E F, CVIKO A, et al. P16 INK4A expression as biomarker for HPV 16 - related vulvar neoplasias [ J ]. Hum Pathol, 2004, 35 (12) : 1477-1483.
  • 6BURNWORTH B, ARENDTA S, MUFFLERA S, et al. The multi -step process of human skin carcinogenesis: A role for p53, cyclin D1, hTERT, P16, and TSP - 1 [J]. Eur J Cell Biol, 2007, 86(11/12) : 763 -780.
  • 7Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix[J]. J Natl Cancer Inst, 1999, 91(3): 252-258.
  • 8National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology cervical cancer screening (v.2.2012)[EB/OL]. http://www.nccn.orglprofes- sionals/physician_gls/pdf/cervical_screening.pdf.
  • 9Shi J, Liu H, Wilkerson M, et al. Evaluation of pl6INK4a, minichromosome maintenance protein 2, DNA topoiso- merase II alpha, ProEX C, and pl6INK4a/ProEX C in cer- vical squamous intraepithelial lesions[J]. Hum Pathol, 2007, 38(9): 1335-1344.
  • 10Ozaki S, Zen Y, Inoue M. Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions[J]. Hum Pathol, 2011, 42(7): 1007-1012.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部